IPO pricing in U.S. biotechnology industry 2014-2016
This statistic shows the quarterly biotechnology IPO pricing in the United States from 2014 to 2016, sorted by the expected price range. In the second quarter of 2015, 27 percent of IPO prices were below their expected range.